Australia markets close in 4 hours 6 minutes

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.8000+0.1100 (+4.09%)
At close: 04:00PM EDT
2.8300 +0.03 (+1.07%)
After hours: 04:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 21.75M
Enterprise value -13.74M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.64
Price/book (mrq)0.80
Enterprise value/revenue -6.70
Enterprise value/EBITDA 0.38

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 3-11.11%
S&P500 52-week change 325.01%
52-week high 34.5500
52-week low 32.4100
50-day moving average 32.8556
200-day moving average 33.1210

Share statistics

Avg vol (3-month) 319.77k
Avg vol (10-day) 314.72k
Shares outstanding 58.12M
Implied shares outstanding 68.12M
Float 85.31M
% held by insiders 134.83%
% held by institutions 129.30%
Shares short (28 Mar 2024) 4287.46k
Short ratio (28 Mar 2024) 411.21
Short % of float (28 Mar 2024) 45.02%
Short % of shares outstanding (28 Mar 2024) 43.55%
Shares short (prior month 29 Feb 2024) 4297.8k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Mar 2020
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,211.14%

Management effectiveness

Return on assets (ttm)-40.53%
Return on equity (ttm)-78.34%

Income statement

Revenue (ttm)2.05M
Revenue per share (ttm)0.25
Quarterly revenue growth (yoy)61.30%
Gross profit (ttm)N/A
EBITDA -36.57M
Net income avi to common (ttm)-34.03M
Diluted EPS (ttm)-4.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)36.08M
Total cash per share (mrq)4.45
Total debt (mrq)585k
Total debt/equity (mrq)2.14%
Current ratio (mrq)5.70
Book value per share (mrq)3.37

Cash flow statement

Operating cash flow (ttm)-31.09M
Levered free cash flow (ttm)-19.55M